Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W.P. Gielis
The Zodiak Trial: Protocol of a Double-Blind, Placebo-Controled, Two-Year Clinical Trial of Zoledronic Acid as a Disease-Modifying Drug in Knee Osteoarthritis With Bone Marrow Lesions
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Related publications
A Double Blind, Multicentre, Placebo Controlled Trial of Lornoxicam in Patients With Osteoarthritis of the Hip and Knee.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Platelet-Rich Plasma and Plasma for Treatment of Knee Osteoarthritis: A Double-Blind Placebo-Controlled Randomized Clinical Trial
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Chondroitin Sulfate Plus Glucosamine Sulfate Does Not Show Superiority Over Placebo in a Randomised, Double Blind, Placebo-Controlled Clinical Trial in Patients With Knee Osteoarthritis
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Treatment of Pain Associated to Knee Osteoarthritis in the Elderly: A Randomized Double-Blind Clinical Trial With Lysine Clonixinate
Revista Dor
The Effectiveness of Kinesio Taping® for Pain Management in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Clinical Trial
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
CR4056, a First-In-Class Imidazoline-2 Receptor Ligand Analgesic, in Pain From Knee Osteoarthritis Phenotypes: A Randomized, Placebo-Controlled, Double-Blind, Phase Iia Clinical Trial
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
